Review paper
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
Abstract
Immunotherapy in the metastatic setting has drastically altered the landscape of treatment for various types of malignancy, including colorectal cancer. The category of immune checkpoint inhibitors has especially emerged as a class of therapy predicated on a more comprehensive understanding of immune cell-cancer cell regulation and evolution of the tumor microenvironment over time. Strategies including adoptive cellular therapies, tumor...
Paper Details
Title
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
Published Date
May 14, 2021
Volume
22
Pages
1 - 12